NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jaeger U
Medizinische Universität Wien - Vienna / Austria
Others
AD Scientific Index ID: 1391748
Medical University Vienna
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jaeger U's MOST POPULAR ARTICLES
1-)
Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphomaSJ Schuster, MR Bishop, CS Tam, EK Waller, P Borchmann, JP McGuirk, ...New England Journal of Medicine 380 (1), 45-56, 201924332019
2-)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by …M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ...The lancet oncology 7 (5), 379-391, 200624032006
3-)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialM Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ...The Lancet 376 (9747), 1164-1174, 201022472010
4-)
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemiaJC Byrd, JR Brown, S O\'Brien, JC Barrientos, NE Kay, NM Reddy, ...New England Journal of Medicine 371 (3), 213-223, 201420072014
5-)
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferationTJ McDonnell, N Deane, FM Platt, G Nunez, U Jaeger, JP McKearn, ...Cell 57 (1), 79-88, 198916291989
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept